Search results for “IRAK4” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 618 patents, we discovered top 41 key players by total patent application. Bristol Myers Squibb Co., Aurigene Discovery Technologies Ltd., Pfizer Inc. are dominant in this area. They take 33.98% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 75
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 74
Pfizer Inc.
New York, United States
Patent: 61
Biogen MA, Inc.
Massachusetts, United States
Patent: 60
Gilead Sciences, Inc.
California, United States
Patent: 45
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 33
Curis, Inc.
Massachusetts, United States
Patent: 25
Bayer Pharma AG
Berlin, Germany
Patent: 23
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 22
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 19
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 403 patents applied in the last 5 years. We discover 45 most active companies in this area. The fast-growing Biogen MA, Inc., Bristol Myers Squibb Co., Gilead Sciences, Inc. take 35.73% of patent filing during this period.
Biogen MA, Inc.
Massachusetts, United States
Patent: 51
Bristol Myers Squibb Co.
New York, United States
Patent: 48
Gilead Sciences, Inc.
California, United States
Patent: 45
Curis, Inc.
Massachusetts, United States
Patent: 25
Pfizer Inc.
New York, United States
Patent: 25
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 22
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 20
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 17
Shanghai Leading Tac Pharma Co., Ltd.
Shanghai Shi, China
Patent: 16
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 15
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 403 patents in last 5 years, we discover 31 new entrants. Gilead Sciences, Inc., Curis, Inc., Kymera Therapeutics, Inc. are the most active new entrants in this area.
Gilead Sciences, Inc.
California, United States
Patent: 45
Curis, Inc.
Massachusetts, United States
Patent: 25
Kymera Therapeutics, Inc.
Massachusetts, United States
Patent: 22
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 17
Shanghai Leading Tac Pharma Co., Ltd.
Shanghai Shi, China
Patent: 16
Nanjing Mingde New Drug Research and Development Co., Ltd.
China
Patent: 13
Dermira, Inc.
California, United States
Patent: 11
Nurix Therapeutics, Inc.
California, United States
Patent: 9
Zhuhai Yufan Biotechnologies Co., Ltd
China
Patent: 8
Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 6 universities and scientific research institutions by total patent application. University of Rochester, Northwestern University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 63.64% of the total patent filing.
University of Rochester
New York, United States
Patent: 4
Northwestern University
Illinois, United States
Patent: 3
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1
Hyogo College of Medicine
Hokkaido, Japan
Patent: 1
Shanghai Institute of Technology
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: